NASDAQ:TSLA

Goldman Sachs (NYSE: GS) Downgrades Tesla (NASDAQ: TSLA): Valuation Concerns and FSD Challenges

Font: Financial Modeling Prep  • Apr 20, 2026

Market Chart
  • Goldman Sachs (NYSE: GS) downgraded Tesla (NASDAQ: TSLA) to a Sell rating, citing high valuation and core business challenges.
  • Investor optimism for Tesla heavily relies on future technologies like autonomous driving, robotaxis, and robotics.
  • The company's high valuation is questioned due to its reliance on undeveloped Full Self-Driving (FSD) software and slower growth compared to the market.

On April 20, 2026, investment firm Goldman Sachs (NYSE: GS) downgraded Tesla (NASDAQ: TSLA) from a Neutral to a Sell rating. This change in outlook occurred when the stock price was $391.18. Tesla is a prominent company known for its electric vehicles (EVs), but it also operates in energy storage and solar panel manufacturing.

The company's future ambitions extend beyond its current EV market position. Investor optimism often focuses on CEO Elon Musk's vision for autonomous driving, robotaxis, and robotics. Tesla uses a unique approach with cameras and a neural network for self-driving, unlike competitors who rely on lidar, sensors, and radar technology.

The downgrade reflects a bearish, or negative, view of the company's prospects. This perspective points to Tesla's high valuation and challenges in its core business. While the stock was a top performer in the last decade, its growth has slowed compared to the market over the past five years.

This bearish case is supported by the company's heavy reliance on technologies that are not yet fully developed. As highlighted by Morgan Stanley (NYSE: MS), Tesla must show "tangible progress" with its Full Self-Driving (FSD) software to support its high stock price. This uncertainty contributes to investor caution ahead of earnings reports.

Reflecting this sentiment, Tesla shares recently declined more than 2% to $391.05. This drop occurred despite a nearly 15% rally the previous week. The company maintains a very large market capitalization, which is the total value of all its shares, of approximately $1.47 trillion, with a daily trading volume over 54.2 million shares.

Market Overview
TOVX
Theriva Biologics, Inc.
$0.41
59.41%
FCHL
Fitness Champs Holdings Limited Common Stock
$0.23
-37.22%
CTNT
Cheetah Net Supply Chain Service Inc.
$0.05
-42.50%
CMND
Clearmind Medicine Inc.
$1.14
58.42%
BYND
Beyond Meat, Inc.
$1.16
41.02%
ENVB
Enveric Biosciences, Inc.
$3.65
100.55%
WLDS
Wearable Devices Ltd.
$1.30
-13.91%
TZA
Direxion Daily Small Cap Bear 3X ETF
$5.00
-1.57%
LZMH
LZ Technology Holdings Limited Class B Ordinary Shares
$0.16
-10.71%
NVDA
NVIDIA Corporation
$202.06
0.19%